Emerging Incidence of Enterococcus faecium among Hospital Isolates (1993 to 2002)-Reference-Cited by-同舟云学术

Emerging Incidence of Enterococcus faecium among Hospital Isolates (1993 to 2002)

Published:2005-01 Issue:1 Volume:43 Page:462-463
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Treitman Adam N.¹,Yarnold Paul R.¹,Warren John¹,Noskin Gary A.¹

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, and Departments of Emergency Medicine and Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Abstract

ABSTRACT Historically, most clinical microbiology laboratories report that 80 to 90% of enterococci are Enterococcus faecalis , whereas E. faecium accounts for 5 to 10% of isolates. At our medical center from 1993 to 2002, we evaluated the percentages of E. faecium among all enterococcal isolates and the percentages of E. faecium isolates that were vancomycin resistant. Over this 10-year period, the percentage of enterococci that were identified as E. faecium increased from 12.7 to 22.2% ( P < 0.001) and the proportion of E. faecium that was vancomycin resistant increased from 28.9 to 72.4% ( P < 0.001). Both the percentage of E. faecium among the enterococci and the proportion of vancomycin-resistant E. faecium increased significantly over this 10-year period.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.43.1.462-463.2005

Reference16 articles.

1. Centers for Disease Control and Prevention. 1995. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morb. Mortal. Wkly. Rep. Recomm. Rep.44(RR-12):1-13.

2. Facklam R. R. D. F. Sahm and L. M. Teixeira. 1999. Enterococcus p. 297-305. In P. R. Murray E. J. Baron M. A. Pfaller F. C. Tenover and R. H. Yolken (ed.) Manual of clinical microbiology 7th ed. American Society for Microbiology Washington D.C.

3. Hoge, C. W., J. Adam, B. Buchanan, and S. Sears. 1991. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev. Infect. Dis.13:600-605.

4. Gonzales, R. D., P. C. Schreckenberger, M. B. Graham, S. Kelkar, K. Denbesten, and J. P. Quinn. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet357:1179.

5. Low, D. L., N. Keller, A. Barth, and R. Jones. 2001. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis.32(Suppl. 2):S133-S145.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity-based protein profiling of serine hydrolases and penicillin-binding proteins in Enterococcus faecium;FEMS Microbes;2024

2. Alteration of the oral and gut microbiota in patients with Kawasaki disease;PeerJ;2023-07-10

3. Investigating the Relationship between Pharmacokinetics/pharmacodynamics of Vancomycin and Clinical Outcome for <i>Enterococcus faecium</i> Bloodstream Infection: a Single-center Retrospective Study;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2023-04-10

4. Antimicrobial susceptibility pattern of enterococci isolated from various clinical samples in a tertiary care hospital in India;IMC Journal of Medical Science;2023-03-19

5. Microbial spectrum and drug resistance of pathogens cultured from gallbladder bile specimens of patients with cholelithiasis: A single-center retrospective study;World Journal of Gastrointestinal Surgery;2022-12-27